Arax Advisory Partners’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTX
Arax Advisory Partners's BNTX Position: Q3 2026 in Review
Arax Advisory Partners reduced its BioNTech (BNTX) stake by 2.4% in Q3 2026, selling an estimated $2.82K and leaving 1,165 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #2724.
Arax Advisory Partners first reported a position in BNTX in Q2 2025 and has held it in 5 quarters since. 302 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.
- Arax Advisory Partners held 1,165 shares of BioNTech worth $115K as of Q3 2026.
- Arax Advisory Partners sold 29 BioNTech shares in Q3 2026, an estimated $2.82K.
- BioNTech made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2724 holding.
- Arax Advisory Partners first reported a position in BioNTech in Q2 2025 and has held it in 5 quarters since.
- 302 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.